scholarly article | Q13442814 |
P50 | author | Nam-Joon Yi | Q38544937 |
YoungRok Choi | Q49197691 | ||
Kyung-Suk Suh | Q49468529 | ||
Kwang-Woong Lee | Q57010951 | ||
Geun Hong | Q57010965 | ||
Min-Su Park | Q85905778 | ||
Hae Won Lee | Q85905781 | ||
Suk-Won Suh | Q87421989 | ||
Tae Yoo | Q87421991 | ||
Myoung Hee Park | Q87926162 | ||
P2093 | author name string | Kyungbun Lee | |
P2860 | cites work | Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey | Q30004207 |
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies | Q34206939 | ||
Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft | Q35911619 | ||
The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation | Q35975914 | ||
Humoral theory of transplantation: further evidence | Q36228533 | ||
Successful renal transplantation with desensitization in highly sensitized patients: a single center experience | Q37078119 | ||
Early plasmapheresis and rituximab for acute humoral rejection after ABO-compatible liver transplantation | Q37267474 | ||
The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline. | Q37644840 | ||
Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients | Q37827197 | ||
Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologist | Q37832763 | ||
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation | Q41343480 | ||
Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury | Q42574211 | ||
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation | Q43683086 | ||
Positive T lymphocytotoxic cross-match in living donor liver transplantation | Q44606831 | ||
Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores | Q44749306 | ||
Successful rescue therapy with plasmapheresis and intravenous immunoglobulin for acute humoral renal transplant rejection | Q45061984 | ||
Comparative analysis of outcome following liver transplantation in US veterans | Q45333555 | ||
Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation | Q46934550 | ||
Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease | Q47199260 | ||
Assessing risk in liver transplantation. Special reference to the significance of a positive cytotoxic crossmatch. | Q51016759 | ||
Antidonor antibody in patients receiving ABO-identical and HLA-mismatched living donor liver transplants: effect on survival. | Q51765327 | ||
Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? | Q53346777 | ||
Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume. | Q53661718 | ||
Re-examination of the Lymphocytotoxic Crossmatch in Liver Transplantation: Can C4d Stains Help in Monitoring? | Q62617379 | ||
Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation | Q73575601 | ||
Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation | Q79296636 | ||
C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status | Q80308091 | ||
An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation | Q80701865 | ||
Present status of ABO-incompatible living donor liver transplantation in Japan | Q81422881 | ||
Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation | Q81604766 | ||
Liver recipients harbouring anti-donor preformed lymphocytotoxic antibodies exhibit a poor allograft survival at the first year after transplantation: experience of one centre | Q81813232 | ||
Human leukocyte antigen crossmatch testing is important for liver retransplantation | Q83150370 | ||
Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease | Q83898477 | ||
P433 | issue | 5 | |
P921 | main subject | desensitization | Q2700499 |
end-stage liver disease | Q54974362 | ||
P304 | page(s) | 640-647 | |
P577 | publication date | 2014-04-25 | |
P1433 | published in | Journal of Korean Medical Science | Q24039955 |
P1476 | title | Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume | |
P478 | volume | 29 |
Q38907391 | Evaluation of donor workups and exclusions in a single-center experience of living donor liver transplantation. |
Q35715908 | Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation |
Q47148342 | Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother. |
Search more.